SE9703274L - Olja-i-vattenemulsioner innehållande propofol och edetat - Google Patents

Olja-i-vattenemulsioner innehållande propofol och edetat

Info

Publication number: SE9703274L
Authority: SE; Sweden
Prior art keywords: oil; edetate; water; water emulsions; emulsions containing
Prior art date: 1994-03-22

Application number

SE9703274A

Other languages

English (en)

Other versions

SE523909C2 (sv

SE9703274D0 (sv

Inventor

Christopher Buchan Jones

John Henry Platt

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-22

Filing date

1997-09-10

Publication date

1997-09-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48793621&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9703274(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-09-10 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1997-09-10 Publication of SE9703274L publication Critical patent/SE9703274L/sv

1997-09-10 Publication of SE9703274D0 publication Critical patent/SE9703274D0/sv

2004-06-01 Publication of SE523909C2 publication Critical patent/SE523909C2/sv

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Botany (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Anesthesiology (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Colloid Chemistry (AREA)
Cosmetics (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Fats And Perfumes (AREA)

SE9703274A 1994-03-22 1997-09-10 Olja-i-vattenemulsioner innehållande propofol och edetat SE523909C2 (sv)

Applications Claiming Priority (19)

Application Number	Priority Date	Filing Date	Title
GB9405593A GB9405593D0 (en)	1994-03-22	1994-03-22	Pharmaceutical compositions
FR9503128A FR2731617B1 (fr)	1994-03-22	1995-03-17	Compositions pharmaceutiques nouvelles contenant du propofol
EP95911412A EP0814787B1 (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol and disodium edetate
DE19509828A DE19509828A1 (de)	1994-03-22	1995-03-17	Pharmazeutische Zusammensetzungen
CH00393/03A CH693762A5 (de)	1994-03-22	1995-03-17	Wässrige Zusammensetzungen enthaltend eine Öl-in-Wasser-Emulsion
CH01282/04A CH694423A5 (de)	1994-03-22	1995-03-17	Verwendung von Edetat zur Stabilisierung von pharmzeutischen Zusammensetzungen.
PCT/GB1995/000579 WO1996029064A1 (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol and edetate
PL95322278A PL186354B1 (pl)	1994-03-22	1995-03-17	Jałowe kompozycje farmaceutyczne oraz sposoby ograniczania potencjału wzrostowego drobnoustrojów i poprawiania czasu stosowania emulsji
HU9702180A HU227951B1 (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol and disodium edetate
ZA952239A ZA952239B (en)	1994-03-22	1995-03-17	Pharmaceutical compositions
NZ500588A NZ500588A (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol and edetate for producing anaesthesia
BE9500241A BE1009198A5 (fr)	1994-03-22	1995-03-17	Compositions pharmaceutiques nouvelles contenant du propofol.
CA002212794A CA2212794C (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol and edetate
CH02011/97A CH693764A5 (de)	1994-03-22	1995-03-17	Pharmazeutische Zusammensetzung enthaltend Propofol und Edetat.
NZ282005A NZ282005A (en)	1994-03-22	1995-03-17	Oil in water emulsions containing propofol (2,6 diisopropylphenol) and edetate
BR9510452A BR9510452A (pt)	1994-03-22	1995-03-17	Composição farmacêutica e aquosa estéril para a administração parenteral processos para limitar o potencial de crescimento microbiano em composição farmacêutica estéril para a administração parenteral para produzir anestesia em um animal de sangue quente e para aperfeiçoar o tempo de administração e/ou o tempo entre as trocas de conjuntos
NO19974278A NO320007B1 (no)	1994-03-22	1997-09-16	Steril farmasoytisk blanding inneholdende propofol og edetat for parenteral administrering, fremgangsmate for a begrense potensialet for mikrobevekst i blandingen, samt anvendelse derav.
JP00624199A JP4012328B2 (ja)	1994-03-22	1999-01-13	エデテートを含有する水中油滴エマルジョン
FI20085586A FI120641B (sv)	1994-03-22	2008-06-13	Fettemulsioner för parenteral administrering, vilka innehåller edetat som konserveringsmedel

Publications (3)

Publication Number	Publication Date
SE9703274L true SE9703274L (sv)	1997-09-10
SE9703274D0 SE9703274D0 (sv)	1997-09-10
SE523909C2 SE523909C2 (sv)	2004-06-01

Family

ID=48793621

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SE9703274A SE523909C2 (sv)	1994-03-22	1997-09-10	Olja-i-vattenemulsioner innehållande propofol och edetat
SE0400115A SE527123C2 (sv)	1994-03-22	2004-01-21	Olja-I-vattenemulsioner innehållande propofol och edetat

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SE0400115A SE527123C2 (sv)	1994-03-22	2004-01-21	Olja-I-vattenemulsioner innehållande propofol och edetat

Country Status (32)

Country	Link
US (1)	US5714520A (sv)
EP (2)	EP0814787B1 (sv)
JP (2)	JP3067806B2 (sv)
AT (2)	ATE226817T1 (sv)
AU (1)	AU710143B2 (sv)
BE (1)	BE1009198A5 (sv)
BR (1)	BR9510452A (sv)
CA (1)	CA2212794C (sv)
CH (4)	CH694396A5 (sv)
CZ (1)	CZ297549B6 (sv)
DE (2)	DE69528714T2 (sv)
DK (3)	DK0814787T3 (sv)
ES (2)	ES2253469T3 (sv)
FI (2)	FI120640B (sv)
FR (1)	FR2731617B1 (sv)
GB (2)	GB9405593D0 (sv)
HU (1)	HU227951B1 (sv)
IL (1)	IL113021A (sv)
IT (1)	IT1281193B1 (sv)
LU (1)	LU90136B1 (sv)
MX (1)	MX9707005A (sv)
NO (2)	NO320007B1 (sv)
NZ (2)	NZ282005A (sv)
PL (1)	PL186354B1 (sv)
PT (1)	PT814787E (sv)
RU (1)	RU2147432C1 (sv)
SE (2)	SE523909C2 (sv)
SI (1)	SI0814787T1 (sv)
SK (1)	SK286375B6 (sv)
TW (1)	TW458781B (sv)
WO (1)	WO1996029064A1 (sv)
ZA (1)	ZA952239B (sv)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6749868B1 (en)	1993-02-22	2004-06-15	American Bioscience, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US5916596A (en) *	1993-02-22	1999-06-29	Vivorx Pharmaceuticals, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en) *	1994-03-22	1994-05-11	Zeneca Ltd	Pharmaceutical compositions
MY113046A (en) *	1994-03-22	2001-11-30	Astrazeneca Uk Ltd	Pharmaceutical compositions
US20020173547A1 (en)	1994-03-22	2002-11-21	Jones Christopher Buchan	Pharmaceuticals compositions
US5637625A (en) *	1996-03-19	1997-06-10	Research Triangle Pharmaceuticals Ltd.	Propofol microdroplet formulations
KR19980025601A (ko) *	1996-10-04	1998-07-15	우동일	혈관주사제용 프로포폴 유탁액의 제조방법
CH692322A5 (it)	1997-05-26	2002-05-15	Westy Ag	Formulazione iniettabile limpida di Propofol.
US8853260B2 (en)	1997-06-27	2014-10-07	Abraxis Bioscience, Llc	Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
DE19757224A1 (de)	1997-12-22	1999-07-01	Bayer Ag	Verfahren und Vorrichtung zur in-situ-Formulierung einer Arzneistofflösung zur parenteralen Applikation
ES2292233T3 (es) *	1998-02-10	2008-03-01	Sicor Inc.	Composicion de propofol que contiene sulfito.
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
US6254853B1 (en)	1998-05-08	2001-07-03	Vyrex Corporation	Water soluble pro-drugs of propofol
AU759641B2 (en) *	1998-08-19	2003-04-17	Skyepharma Canada Inc.	Injectable aqueous dispersions of propofol
US6150423A (en)	1998-10-15	2000-11-21	Phoenix Scientific, Inc.	Propofol-based anesthetic and method of making same
US6028108A (en) *	1998-10-22	2000-02-22	America Home Products Corporation	Propofol composition comprising pentetate
US6140374A (en) *	1998-10-23	2000-10-31	Abbott Laboratories	Propofol composition
US6140373A (en) *	1998-10-23	2000-10-31	Abbott Laboratories	Propofol composition
US6682758B1 (en)	1998-12-22	2004-01-27	The United States Of America As Represented By The Department Of Health And Human Services	Water-insoluble drug delivery system
ES2232195T3 (es) *	1999-01-28	2005-05-16	Dinesh Shantilal Patel	Solucion parenteral de propofol (2,6-diisopropilfenol) y 2,5-di-o-metil-1,4;3,6-dianhidro-d-glucitol como solvente.
US6177477B1 (en) *	1999-03-24	2001-01-23	American Home Products Corporation	Propofol formulation containing TRIS
US6100302A (en) *	1999-04-05	2000-08-08	Baxter International Inc.	Propofol formulation with enhanced microbial characteristics
AU5574200A (en) *	1999-06-21	2001-01-09	Kuhnil Pharm. Co., Ltd.	Anesthetic composition for intravenous injection comprising propofol
GB2359747B (en) *	2000-02-29	2002-04-24	Maelor Pharmaceuticals Ltd	Anaesthetic formulations
SE0001865D0 (sv) *	2000-05-19	2000-05-19	Astrazeneca Ab	Management of septic shock
GB0012597D0 (en) *	2000-05-25	2000-07-12	Astrazeneca Ab	Formulation
IL152774A0 (en) *	2000-05-25	2003-06-24	Astrazeneca Ab	Pharmaceutical composition comprising a free-radical scavenging sedative agent and a metal ion chelating agent
IL153457A0 (en)	2000-06-16	2003-07-06	Skyepharma Canada Inc	Improved injectable dispersions of propofol
IN188917B (sv) *	2000-12-07	2002-11-23	Bharat Surums & Vaccines Ltd
US6399087B1 (en) *	2000-12-20	2002-06-04	Amphastar Pharmaceuticals, Inc.	Propofol formulation with enhanced microbial inhibition
CN1525856A (zh)	2001-05-11	2004-09-01	三菱制药株式会社	含吡唑啉酮衍生物的稳定的高浓度注射剂
JP4127757B2 (ja) *	2001-08-21	2008-07-30	株式会社エヌ・ティ・ティ・ドコモ	無線通信システム、通信端末装置、及びバースト信号送信方法
US20030054042A1 (en) *	2001-09-14	2003-03-20	Elaine Liversidge	Stabilization of chemical compounds using nanoparticulate formulations
US8541472B2 (en)	2001-12-05	2013-09-24	Aseptica, Inc.	Antiseptic compositions, methods and systems
ES2325918T3 (es) *	2001-12-28	2009-09-24	Eisai Corporation Of North America	Formulaciones farmaceuticas de base acuosa de profarmacos de propofol solubles en agua.
KR100951846B1 (ko)	2002-01-25	2010-04-12	세라밴스 인코포레이티드	마취 및 진정을 위한 단기 작용 진정최면제
US20080220075A1 (en) *	2002-03-20	2008-09-11	Elan Pharma International Ltd.	Nanoparticulate compositions of angiogenesis inhibitors
EP1490030B2 (en) *	2002-03-20	2010-07-14	Elan Pharma International Limited	Nanoparticulate compositions of angiogenesis inhibitors
JP5188003B2 (ja) *	2002-04-08	2013-04-24	エーザイインコーポレイテッド	プロポフォールの水溶性プロドラッグを含む薬学的組成物およびその投与方法
US7550155B2 (en)	2002-07-29	2009-06-23	Transform Pharmaceuticals Inc.	Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
RS54275B1 (sr)	2002-07-29	2016-02-29	Transform Pharmaceuticals, Inc.	Vodeni 2,6-diizopropilfenol farmaceutski sastavi
AU2003286725B2 (en) *	2002-10-29	2007-07-12	Transform Pharmaceuticals, Inc.	Propofol with cysteine
LT1585548T (lt)	2002-12-09	2018-09-25	Abraxis Bioscience, Llc	Farmakologinių agentų kompozicijos ir įvedimo būdai
US20040225022A1 (en) *	2003-05-09	2004-11-11	Desai Neil P.	Propofol formulation containing reduced oil and surfactants
US8476010B2 (en)	2003-07-10	2013-07-02	App Pharmaceuticals Llc	Propofol formulations with non-reactive container closures
DE602004023509D1 (de) *	2003-07-23	2009-11-19	Theravance Inc	Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels
US8546453B2 (en)	2003-08-14	2013-10-01	Rensheng Zhang	Propofol compositions and methods for reducing pain associated with propofol injection
CA2543166A1 (en) *	2003-10-24	2005-05-19	Auspex Pharmaceuticals, Inc.	Ph sensitive prodrugs of 2,6-diisopropylphenol
JP5165249B2 (ja)	2004-02-13	2013-03-21	バイオアバイラビリティ，インク．	麻酔用高濃度プロポフォールのマイクロエマルジョンの調製
AU2005283726A1 (en) *	2004-09-13	2006-03-23	Bharat Serums & Vaccines Ltd.	Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US8557861B2 (en) *	2004-09-28	2013-10-15	Mast Therapeutics, Inc.	Low oil emulsion compositions for delivering taxoids and other insoluble drugs
EP1850829A4 (en) *	2005-02-03	2012-12-26	Taro Pharmaceuticals Usa Inc	NEW PROPOLFOL COMPOSITION WITH ASCORBIC ACID OR PHARMACEUTICALLY USEFUL SALTS
JP2008530236A (ja)	2005-02-18	2008-08-07	アブラクシスバイオサイエンス、インコーポレイテッド	虚血障害用の、２，６−ジイソプロピルフェノール及び類似体の組成物、使用及び調製方法。
WO2006128088A1 (en) *	2005-05-27	2006-11-30	Sandhya Goyal	Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
RU2290169C1 (ru) *	2005-06-23	2006-12-27	Открытое Акционерное Общество "Фаберлик"	Косметическое и/или дерматологическое средство и антиоксидант
JP2009503059A (ja) *	2005-08-05	2009-01-29	ブハラットセルムズアンドヴァクシンズリミテッド	防腐効果を有する静脈プロポフォールエマルジョン組成物
US20090203794A1 (en) *	2005-08-12	2009-08-13	Gautam Vinod Daftary	Aqueous Anaesthetic Composition Comprising Propofol
WO2007022437A2 (en) *	2005-08-18	2007-02-22	Auspex Pharmaceuticals, Inc.	Therapeutic agents for the treatment of cancer and metabolic disorders
PT1931321T (pt) *	2005-08-31	2019-05-14	Abraxis Bioscience Llc	Composições compreendendo agentes farmacêuticos pouco hidrossolúveis e agentes antimicrobianos
CA2620389C (en) *	2005-08-31	2014-06-17	Abraxis Bioscience, Llc	Compositions and methods for preparation of poorly water soluble drugs with increased stability
US7589239B2 (en) *	2005-09-02	2009-09-15	Auspex Pharmaceuticals	Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
TWI376239B (en) *	2006-02-01	2012-11-11	Andrew Xian Chen	Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
CN1903187B (zh) *	2006-03-21	2012-05-30	沈阳药科大学	含有局麻药的复方异丙酚注射剂及制备工艺
DK2301908T3 (da)	2007-05-09	2014-09-15	Sowood Healthcare Llc	(-)-stereoisomer af 2,6-di-sec-butylphenol og analoger dertil til frembringelse af en antiemetisk effekt, behandling af kvalme og opkastning og behandling af migræne
AU2008251484A1 (en) *	2007-05-09	2008-11-20	Pharmacofore, Inc.	Therapeutic compounds
KR20080102010A (ko) *	2007-05-17	2008-11-24	대원제약주식회사	프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
NZ591205A (en)	2008-08-01	2012-11-30	Medicines Co	Pharmaceutical compositions comprising clevidipine and methods for producing low impurity concentrations of the same
US9132090B2 (en)	2009-01-13	2015-09-15	Chetan Majmudar	Propofol based anesthetic with preservative
US8658676B2 (en)	2010-10-12	2014-02-25	The Medicines Company	Clevidipine emulsion formulations containing antimicrobial agents
BR112013008601B1 (pt) *	2010-10-12	2020-03-31	Chiesi Farmaceutici S.P.A.	Formulações de emulsão de clevidipina contendo agentes antimicrobianos
CN102525921B (zh)	2012-02-06	2013-08-07	西安力邦制药有限公司	2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
CN102579555A (zh) *	2012-03-01	2012-07-18	四川大学华西医院	注射用脂肪乳在作为拮抗全身麻醉用药作用的药物制备中的应用
MX374014B (es)	2012-05-16	2020-07-24	Mewa Singh	Composiciones farmaceuticas para la entrega de farmacos insolubles en agua.
WO2017031261A1 (en)	2015-08-20	2017-02-23	Mewa Singh	Polyphenolic polymer to make water-insoluble molecules become water-soluble
US11357743B2 (en)	2017-04-19	2022-06-14	Mayo Foundation For Medical Education And Research	Ketamine and propofol admixture

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3384545A (en) *	1965-03-09	1968-05-21	Hoffmann La Roche	Injectable aqueous emulsions of fat soluble vitamins
US3230143A (en) *	1965-05-14	1966-01-18	Merck & Co Inc	Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
DE1792410B2 (de) *	1967-09-01	1980-03-13	Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm	Arzneimittelzubereitung zur intravenösen Injektion
US4798846A (en) *	1974-03-28	1989-01-17	Imperial Chemical Industries Plc	Pharmaceutical compositions
GB1472793A (en) *	1974-03-28	1977-05-04	Ici Ltd	Pharmaceutical compositions
US4328213A (en) *	1979-11-28	1982-05-04	Schering Corporation	Stable injectable labetalol formulation
DE3225706C2 (de) *	1982-07-09	1984-04-26	A. Nattermann & Cie GmbH, 5000 Köln	Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
JPS5916818A (ja) *	1982-07-20	1984-01-28	Shimizu Seiyaku Kk	経静脈投与用輸液剤
SE8505047L (sv) *	1985-10-25	1987-04-26	Nutritional Int Res Inst	Fettemulsion
IL83086A (en) *	1987-07-06	1991-03-10	Teva Pharma	Stable,injectable solutions of vincristine salts
US4868169A (en) *	1987-11-13	1989-09-19	E. R. Squibb & Sons, Inc.	Steroid cream formulation
JPH075456B2 (ja) *	1988-10-01	1995-01-25	参天製薬株式会社	点眼液
WO1990006055A1 (en) *	1988-11-29	1990-06-14	Unilever Plc	Antimicrobial agents and uses thereof
GB8828517D0 (en) *	1988-12-07	1989-01-11	Leopold & Co Ag	Stable emulsions
US5079003A (en) *	1990-03-14	1992-01-07	Adelia Scaffidi	Skin lotions and creams
JP3308555B2 (ja) *	1991-03-08	2002-07-29	カネボウ株式会社	微細化エマルション組成物の製造方法
US5322689A (en) *	1992-03-10	1994-06-21	The Procter & Gamble Company	Topical aromatic releasing compositions
JP2811036B2 (ja) *	1992-05-26	1998-10-15	参天製薬株式会社	ビタミンｅ点眼剤
GB9405593D0 (en) *	1994-03-22	1994-05-11	Zeneca Ltd	Pharmaceutical compositions
US5616330A (en) *	1994-07-19	1997-04-01	Hemagen/Pfc	Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
PT835097E (pt) *	1995-06-06	2001-12-28	Biomolecular Products Inc	Particulas mistas de lipido de bicarbonato coloidal para distribuicao de drogas ou calorias

1994
- 1994-03-22 GB GB9405593A patent/GB9405593D0/en active Pending
1995
- 1995-03-17 RU RU97117100A patent/RU2147432C1/ru active
- 1995-03-17 DE DE69528714T patent/DE69528714T2/de not_active Expired - Lifetime
- 1995-03-17 IL IL11302195A patent/IL113021A/en not_active IP Right Cessation
- 1995-03-17 SK SK1247-97A patent/SK286375B6/sk not_active IP Right Cessation
- 1995-03-17 DK DK95911412T patent/DK0814787T3/da active
- 1995-03-17 SI SI9530628T patent/SI0814787T1/xx unknown
- 1995-03-17 BE BE9500241A patent/BE1009198A5/fr active
- 1995-03-17 EP EP95911412A patent/EP0814787B1/en not_active Expired - Lifetime
- 1995-03-17 WO PCT/GB1995/000579 patent/WO1996029064A1/en not_active Ceased
- 1995-03-17 HU HU9702180A patent/HU227951B1/hu unknown
- 1995-03-17 NZ NZ282005A patent/NZ282005A/xx not_active IP Right Cessation
- 1995-03-17 CA CA002212794A patent/CA2212794C/en not_active Expired - Fee Related
- 1995-03-17 GB GB9505405A patent/GB2298789B/en not_active Expired - Lifetime
- 1995-03-17 PL PL95322278A patent/PL186354B1/pl unknown
- 1995-03-17 CH CH02053/03A patent/CH694396A5/de not_active IP Right Cessation
- 1995-03-17 TW TW084102594A patent/TW458781B/zh not_active IP Right Cessation
- 1995-03-17 PT PT95911412T patent/PT814787E/pt unknown
- 1995-03-17 AT AT95911412T patent/ATE226817T1/de active
- 1995-03-17 CH CH00393/03A patent/CH693762A5/de not_active IP Right Cessation
- 1995-03-17 EP EP02009330A patent/EP1238677B1/en not_active Expired - Lifetime
- 1995-03-17 FR FR9503128A patent/FR2731617B1/fr not_active Expired - Lifetime
- 1995-03-17 MX MX9707005A patent/MX9707005A/es unknown
- 1995-03-17 DE DE19509828A patent/DE19509828A1/de not_active Ceased
- 1995-03-17 CZ CZ0290497A patent/CZ297549B6/cs not_active IP Right Cessation
- 1995-03-17 IT IT95MI000529A patent/IT1281193B1/it active IP Right Grant
- 1995-03-17 ES ES02009330T patent/ES2253469T3/es not_active Expired - Lifetime
- 1995-03-17 AU AU18988/95A patent/AU710143B2/en not_active Expired
- 1995-03-17 AT AT02009330T patent/ATE312625T1/de active
- 1995-03-17 ZA ZA952239A patent/ZA952239B/xx unknown
- 1995-03-17 ES ES95911412T patent/ES2183869T3/es not_active Expired - Lifetime
- 1995-03-17 DK DK02009330T patent/DK1238677T3/da active
- 1995-03-17 NZ NZ500588A patent/NZ500588A/en not_active IP Right Cessation
- 1995-03-17 CH CH01282/04A patent/CH694423A5/de not_active IP Right Cessation
- 1995-03-17 JP JP08528148A patent/JP3067806B2/ja not_active Expired - Lifetime
- 1995-03-17 BR BR9510452A patent/BR9510452A/pt not_active IP Right Cessation
- 1995-03-17 CH CH02011/97A patent/CH693764A5/de not_active IP Right Cessation
- 1995-03-22 US US08/408,707 patent/US5714520A/en not_active Expired - Lifetime
1997
- 1997-09-10 SE SE9703274A patent/SE523909C2/sv not_active IP Right Cessation
- 1997-09-10 LU LU90136A patent/LU90136B1/de active
- 1997-09-16 FI FI973702A patent/FI120640B/sv not_active IP Right Cessation
- 1997-09-16 NO NO19974278A patent/NO320007B1/no not_active IP Right Cessation
- 1997-09-17 DK DK106697A patent/DK106697A/da not_active Application Discontinuation
1999
- 1999-01-13 JP JP00624199A patent/JP4012328B2/ja not_active Expired - Lifetime
2004
- 2004-01-21 SE SE0400115A patent/SE527123C2/sv not_active IP Right Cessation
- 2004-05-04 NO NO20041838A patent/NO334956B1/no not_active IP Right Cessation
2008
- 2008-06-13 FI FI20085586A patent/FI120641B/sv not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK1238677T3 (da)	2006-03-06
SE0400115L (sv)	2004-01-21
PL322278A1 (en)	1998-01-19
CH694396A5 (de)	2004-12-31
AU710143B2 (en)	1999-09-16
CH693764A5 (de)	2004-01-30
WO1996029064A1 (en)	1996-09-26
HUT77358A (hu)	1998-03-30
FI120641B (sv)	2010-01-15
NO974278L (no)	1997-09-16
CH694423A5 (de)	2005-01-14
ATE226817T1 (de)	2002-11-15
NO334956B1 (no)	2014-08-04
DE69528714T2 (de)	2003-06-12
EP0814787A1 (en)	1998-01-07
NO320007B1 (no)	2005-10-10
JPH11263725A (ja)	1999-09-28
NZ500588A (en)	2001-04-27
SE527123C2 (sv)	2005-12-27
FR2731617A1 (fr)	1996-09-20
SE523909C2 (sv)	2004-06-01
EP1238677A3 (en)	2003-01-22
BE1009198A5 (fr)	1996-12-03
HK1008927A1 (zh)	1999-07-16
PT814787E (pt)	2003-02-28
SE0400115D0 (sv)	2004-01-21
FI973702A0 (sv)	1997-09-16
LU90136B1 (de)	1997-11-27
NZ282005A (en)	2000-01-28
IL113021A0 (en)	1995-12-08
FI20085586L (sv)	2008-06-13
CH693762A5 (de)	2004-01-30
HU227951B1 (en)	2012-07-30
RU2147432C1 (ru)	2000-04-20
EP1238677A2 (en)	2002-09-11
GB2298789A (en)	1996-09-18
ITMI950529A1 (it)	1996-09-17
JPH11500737A (ja)	1999-01-19
CZ290497A3 (en)	1997-12-17
AU1898895A (en)	1996-10-08
TW458781B (en)	2001-10-11
FR2731617B1 (fr)	1997-05-30
SK124797A3 (en)	1998-01-14
JP3067806B2 (ja)	2000-07-24
DK106697A (da)	1997-09-17
SK286375B6 (sk)	2008-08-05
JP4012328B2 (ja)	2007-11-21
DE69528714D1 (de)	2002-12-05
ES2253469T3 (es)	2006-06-01
GB2298789B (en)	1999-12-08
CZ297549B6 (cs)	2007-02-07
CA2212794A1 (en)	1996-09-26
FI973702L (sv)	1997-09-16
GB9405593D0 (en)	1994-05-11
ITMI950529A0 (it)	1995-03-17
CA2212794C (en)	2000-09-12
FI120640B (sv)	2010-01-15
ATE312625T1 (de)	2005-12-15
PL186354B1 (pl)	2003-12-31
NO974278D0 (no)	1997-09-16
NO20041838L (no)	1997-09-16
ZA952239B (en)	1996-09-17
EP1238677B1 (en)	2005-12-14
ES2183869T3 (es)	2003-04-01
DK0814787T3 (da)	2003-01-06
EP0814787B1 (en)	2002-10-30
BR9510452A (pt)	1998-05-19
SI0814787T1 (en)	2003-04-30
IL113021A (en)	2001-04-30
DE19509828A1 (de)	1996-09-19
SE9703274D0 (sv)	1997-09-10
MX9707005A (es)	1997-11-29
GB9505405D0 (en)	1995-05-03
IT1281193B1 (it)	1998-02-17
US5714520A (en)	1998-02-03

Publication	Publication Date	Title
SE9703274D0 (sv)	1997-09-10	Olja-i-vattenemulsioner innehållande propofol och edetat
IL114212A (en)	1999-07-14	Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
ATE118177T1 (de)	1995-02-15	Emulsion.
KR870002834A (ko)	1987-04-13	유제조성물의 제조방법
DE69011922D1 (de)	1994-10-06	Arzneiemulsionen.
GR3024405T3 (en)	1997-11-28	Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their use
DE69625213D1 (de)	2003-01-16	Mikroemulsionen zur verwendung als träger zur verabreichung von wirkstoffen
RU94046395A (ru)	1996-11-20	Производные полиоксиалкиленов и замещенного янтарного ангидрида, способ обработки шерсти, способ инверсии эмульсии "вода в масле"
ATE333867T1 (de)	2006-08-15	Emulgierte arzneistoffabgabesysteme
ATE365538T1 (de)	2007-07-15	O/w emulsion
ES2114931T3 (es)	1998-06-16	Nuevos esteres esteroidales.
SE8705064L (sv)	1989-06-19	Emulsion foer parenteral administrering
AR008542A1 (es)	2000-01-19	Metodo para provocar la caida de insectos rastreros.
BR0111094A (pt)	2003-04-08	Composição farmacêutica, uso de uma composição farmacêutica estéril, e, método para melhorar a sobrevida em um paciente criticamente doente
FR2692164B1 (fr)	1994-11-10	Procédé d'ultrafiltration d'émulsions stabilisées.

Legal Events

Date	Code	Title	Description
2015-05-05	NUG	Patent has lapsed